However, these results have previously been described in a mouse model of influenza, where treating isolated CD4+ T cells with metformin 2 mM resulted in the inhibition of the oxygen consumption rate (OCR) and the modulation of the CD69 and CD25 [39]. The gene discussed is CD69; the disease is influenza.